Chitosan (CS) is a linear polysaccharide which is achieved by deacetylation of chitin, which is the second most plentiful compound in nature, after cellulose. Chitosan was applied in pharmaceutics/drug/gene delivery and cell encapsulation. Chitosan was applied in binding to protein drugs, contact lenses and implants. GMP grade chitosan covers chitosan for a variety of medical applications.
The industry's leading producers are Primex, KitoZyme and BIO21, with a combined revenue share of 29.72% in 2019.
The global Medical Grade Chitosan market was valued at US$ 32 million in 2020 and is expected to reach US$ 53 million by the end of 2027, growing at a CAGR of 7.8% during 2021-2027.
This report focuses on Medical Grade Chitosan volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Medical Grade Chitosan market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Medical Grade Chitosan Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Animal Origin Chitosan
Plant Based Chitosan
Segment by Application
Wound Care
Healthcare Products
Antibacterial Products
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Primex
KitoZyme
BIO21
YSK
Vietnam Food
NovaMatrix
KIMICA
Ningbo Zhenhai Haixin Biological
Golden-Shell Pharmaceutical
Zhejiang Fengrun Biotech
Jiangsu Shuanglin
Jiangsu Aoxin Biotechnology
Qingdao Yunzhou Biochemistry
The industry's leading producers are Primex, KitoZyme and BIO21, with a combined revenue share of 29.72% in 2019.
The global Medical Grade Chitosan market was valued at US$ 32 million in 2020 and is expected to reach US$ 53 million by the end of 2027, growing at a CAGR of 7.8% during 2021-2027.
This report focuses on Medical Grade Chitosan volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Medical Grade Chitosan market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Medical Grade Chitosan Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Animal Origin Chitosan
Plant Based Chitosan
Segment by Application
Wound Care
Healthcare Products
Antibacterial Products
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Primex
KitoZyme
BIO21
YSK
Vietnam Food
NovaMatrix
KIMICA
Ningbo Zhenhai Haixin Biological
Golden-Shell Pharmaceutical
Zhejiang Fengrun Biotech
Jiangsu Shuanglin
Jiangsu Aoxin Biotechnology
Qingdao Yunzhou Biochemistry
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.